Published in Biol Psychiatry on August 14, 2015
The Role of the Immune System in Autism Spectrum Disorder. Neuropsychopharmacology (2016) 0.82
Prevalence and associated features of autism spectrum disorder in extremely low gestational age newborns at age 10 years. Autism Res (2016) 0.82
Transcutaneous Vagus Nerve Stimulation: A Promising Method for Treatment of Autism Spectrum Disorders. Front Neurosci (2017) 0.77
Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders. Transl Psychiatry (2016) 0.77
Evidence for an immune signature of prenatal alcohol exposure in female rats. Brain Behav Immun (2016) 0.76
A Putative Blood-Based Biomarker for Autism Spectrum Disorder-Associated Ileocolitis. Sci Rep (2016) 0.75
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder. Autism Open Access (2016) 0.75
The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder. Neurosci Bull (2017) 0.75
Behavioral impact of maternal allergic-asthma in two genetically distinct mouse strains. Brain Behav Immun (2016) 0.75
Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord (1994) 42.80
The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord (2000) 37.47
Combining information from multiple sources in the diagnosis of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry (2006) 5.23
The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect (2006) 3.81
Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci (2005) 3.77
Autism spectrum disorders. Neuron (2000) 3.62
Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun (2001) 2.51
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun (2010) 2.44
Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem (2005) 2.12
Early behavioral intervention is associated with normalized brain activity in young children with autism. J Am Acad Child Adolesc Psychiatry (2012) 1.98
Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol (2009) 1.88
Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun (2009) 1.86
Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol (2001) 1.85
Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med (2005) 1.81
Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet (2008) 1.66
Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther (1991) 1.57
Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry (2008) 1.54
Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr Opin Neurol (2010) 1.52
Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism (2011) 1.51
Diagnosing autism spectrum disorders in pre-school children using two standardised assessment instruments: the ADI-R and the ADOS. J Autism Dev Disord (2007) 1.48
Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J Immunol Methods (2008) 1.47
Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function. J Immunol (2007) 1.41
Transfer of inflammatory cytokines across the placenta. Obstet Gynecol (2004) 1.33
Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol (2006) 1.30
Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry (1999) 1.27
Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One (2011) 1.24
Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders. World J Biol Psychiatry (2011) 1.24
Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res (1993) 1.23
Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int J Dev Neurosci (2005) 1.22
Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics (2010) 1.22
Newborn screening for congenital infectious diseases. Emerg Infect Dis (2004) 1.21
Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol (2012) 1.21
Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J Biol Chem (2004) 1.20
The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents. AIDS (2006) 1.19
Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci (2007) 1.11
Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J Neuroimmunol (2009) 1.11
Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun (2010) 1.07
Integrated review of cytokines in maternal, cord, and newborn blood: part I--associations with preterm birth. Biol Res Nurs (2009) 1.01
Low-grade endotoxemia in patients with severe autism. Neurosci Lett (2010) 0.99
Structural and functional deficits in a neuronal calcium sensor-1 mutant identified in a case of autistic spectrum disorder. PLoS One (2010) 0.97
Neuronal cell survival: the role of interleukins. Ann N Y Acad Sci (2009) 0.96
Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci Lett (1993) 0.95
Association of preterm birth with sustained postnatal inflammatory response. Obstet Gynecol (2008) 0.93
Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci (1995) 0.92
Type 1 diabetes risk analysis on dried blood spot samples from population-based newborns: design and feasibility of an unselected case-control study. Paediatr Perinat Epidemiol (2007) 0.92
Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank. J Neuroimmunol (2012) 0.91
Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay. J Autism Dev Disord (2014) 0.91
Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study. J Neuroinflammation (2014) 0.84
Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. Cytokine (2002) 0.82
Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study. Cytokine (2012) 0.81
California Very Preterm Birth Study: design and characteristics of the population- and biospecimen bank-based nested case-control study. Paediatr Perinat Epidemiol (2012) 0.80
Developmentally regulated gene expression of Th2 cytokines in the brain. Brain Res (2000) 0.80
Integrated review of cytokines in maternal, cord, and newborn blood: part II-- associations with early infection and increased risk of neurologic damage in preterm infants. Biol Res Nurs (2009) 0.80
Interleukin-4 blocks proliferation of retinal progenitor cells and increases rod photoreceptor differentiation through distinct signaling pathways. J Neuroimmunol (2008) 0.78
The passage of granulocyte-macrophage colony-stimulating factor across the human placenta perfused in vitro. J Soc Gynecol Investig (2000) 0.77
IL-4 increases GABAergic phenotype in rat retinal cell cultures: involvement of muscarinic receptors and protein kinase C. J Neuroimmunol (2002) 0.77
Exogenous IL-1beta induces its own expression, but not that of IL-6 in the hypothalamus and activates HPA axis and prolactin release. Endocr Regul (2006) 0.76